Tonix Pharmaceuticals announces proposed underwritten public offering of common stock
Tonix Pharma announced it intends to offer shares of its common stock and warrants to purchase common stock in an underwritten public offering. Dawson James Securities is acting as sole book-running manager. Tonix expects to use net proceeds to support development of TNX-102 SL for PTSD. October 25, 2016